finance.yahoo.com
·
Sep 3
HUTCHMED Lands GSK Deal Worth Up to $1.3B for KRAS-EGFR Cancer Therapy
Discussion
0 comments
Want to join the discussion?
Log in
or
create an account.
No comments yet. Start the discussion.